L01EL01 ibrutinib
ATC group of level 5 – chemical substance · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 5 medicines in this group.
- 4 prescription only (POM)
- 1 no longer supplied or not available
Active substance: Ibrutinib – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 8 medicines
- L01EL01 ibrutinib 5 medicines
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 8 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Imbruvica 140 mg film-coated tablets SPC | Prescription only (POM) |
| Imbruvica 140 mg hard capsules SPC no longer supplied | – |
| Imbruvica 280 mg film-coated tablets | Prescription only (POM) |
| Imbruvica 420 mg film-coated tablets SPC | Prescription only (POM) |
| Imbruvica 560 mg film-coated tablets SPC | Prescription only (POM) |
Other groups of the same level
- L01EL02 acalabrutinib 1 medicine
- L01EL03 zanubrutinib 2 medicines
Other names of the ATC group
- German: L01EL01 Ibrutinib
- German: L01EL01 Ibrutinib
- Italian: L01EL01 IBRUTINIB
- Turkish: L01EL01 ibrutinib
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EL01
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.